Literature DB >> 28651293

[Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)].

Tom Schaberg1, Torsten Bauer2,3, Folke Brinkmann4, Roland Diel5,6, Cornelia Feiterna-Sperling7, Walter Haas8, Pia Hartmann9,10, Barbara Hauer8, Jan Heyckendorf11,12,13, Christoph Lange11,12,13,14, Albert Nienhaus15, Ralf Otto-Knapp3,16, Martin Priwitzer17, Elvira Richter18, Rudolf Rumetshofer19, Karl Schenkel3, Otto Dagobert Schoch20, Nicolas Schönfeld2,3, Ralf Stahlmann21.   

Abstract

Since 2015 a significant increase in tuberculosis cases is notified in Germany, mostly due to rising numbers of migrants connected to the recent refugee crisis. Because of the low incidence in previous years, knowledge on tuberculosis is more and more limited to specialized centers. However, lung specialist and healthcare workers of other fields have contact to an increasing number of tuberculosis patients. In this situation, guidance for the management of standard therapy and especially for uncommon situations will be essential. This new guideline on tuberculosis in adults gives recommendations on diagnosis, treatment, prevention and prophylaxis. It provides a comprehensive overview over the current knowledge, adapted to the specific situation in Germany. The German Central Committee against Tuberculosis (DZK e. V.) realized this guideline on behalf of the German Respiratory Society (DGP). A specific guideline for tuberculosis in the pediatrics field will be published separately. Compared to the former recommendations of the year 2012, microbiological diagnostics and therapeutic drug management were given own sections. Chapters about the treatment of drug-resistant tuberculosis, tuberculosis in people living with HIV and pharmacological management were extended. This revised guideline aims to be a useful tool for practitioners and other health care providers to deal with the recent challenges of tuberculosis treatment in Germany. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28651293     DOI: 10.1055/s-0043-105954

Source DB:  PubMed          Journal:  Pneumologie        ISSN: 0934-8387


  20 in total

Review 1.  [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany].

Authors:  Stefan Bittner; Sinah Engel; Christoph Lange; Martin S Weber; Aiden Haghikia; Felix Luessi; Thomas Korn; Luisa Klotz; Antonios Bayas; Friedemann Paul; Christoph Heesen; Martin Stangel; Brigitte Wildemann; Florian Then Bergh; Björn Tackenberg; Corinna Trebst; Clemens Warnke; Ralf Linker; Martin Kerschensteiner; Uwe Zettl; Hayrettin Tumani; Wolfgang Brück; Sven G Meuth; Tanja Kümpfel; Bernhard Hemmer; Heinz Wiendl; Ralf Gold; Frauke Zipp
Journal:  Nervenarzt       Date:  2019-12       Impact factor: 1.214

2.  [Interpretation of tuberculosis and hepatitis screening before immunosuppressive treatment].

Authors:  B Ehrenstein
Journal:  Z Rheumatol       Date:  2018-08       Impact factor: 1.372

3.  [Tuberculosis].

Authors:  Christoph Lange; Barbara Kalsdorf; Florian P Maurer; Jan Heyckendorf
Journal:  Internist (Berl)       Date:  2019-11       Impact factor: 0.743

4.  Open flanks in the management of tuberculosis in Germany under the pressure of migration.

Authors:  Josef A I Weigl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-17       Impact factor: 3.267

Review 5.  Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment.

Authors:  Berthold Jany; Tobias Welte
Journal:  Dtsch Arztebl Int       Date:  2019-05-24       Impact factor: 5.594

6.  Can we predict favourable quality of life after surgically treated vertebral osteomyelitis? Analysis of a prospective study.

Authors:  A Yagdiran; C Otto-Lambertz; B Sondermann; A Ernst; D Jochimsen; R Sobottke; J Siewe; P Eysel; N Jung
Journal:  Arch Orthop Trauma Surg       Date:  2022-03-31       Impact factor: 3.067

7.  Occurrence of extrapulmonary tuberculosis is associated with geographical origin: spatial characteristics of the Frankfurt TB cohort 2013-2018.

Authors:  Nils Wetzstein; Alena-Pauline Drummer; Annabelle Bockey; Eva Herrmann; Claus Philippe Küpper-Tetzel; Christiana Graf; Benjamin Koch; Udo Goetsch; Maria J G T Vehreschild; Lorenzo Guglielmetti; Berit Lange; Thomas A Wichelhaus; Christoph Stephan
Journal:  Infection       Date:  2022-10-01       Impact factor: 7.455

8.  National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs).

Authors:  Eva Rath; Michael Bonelli; Christina Duftner; Johann Gruber; Peter Mandl; Florentine Moazedi-Furst; Herwig Pieringer; Rudolf Puchner; Holger Flick; Helmut J F Salzer; Günter Weiss; Stefan Winkler; Hans Skvara; Alexander Moschen; Harald Hofer; Julia Feurstein; Judith Sautner
Journal:  Wien Klin Wochenschr       Date:  2022-08-29       Impact factor: 2.275

9.  [Septic shock in a female patient with miliary tuberculosis].

Authors:  J Fichte; V Neef; M Schöffner; D Bremerich
Journal:  Anaesthesist       Date:  2018-09-26       Impact factor: 1.041

10.  Latent Tuberculosis Infection among Health Workers in Germany-A Retrospective Study on Progression Risk and Use of Preventive Therapy.

Authors:  Nika Zielinski; Johanna Stranzinger; Hajo Zeeb; Jan Felix Kersten; Albert Nienhaus
Journal:  Int J Environ Res Public Health       Date:  2021-07-01       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.